NO20073294L - G-proteinkoplet reseptor - Google Patents

G-proteinkoplet reseptor

Info

Publication number
NO20073294L
NO20073294L NO20073294A NO20073294A NO20073294L NO 20073294 L NO20073294 L NO 20073294L NO 20073294 A NO20073294 A NO 20073294A NO 20073294 A NO20073294 A NO 20073294A NO 20073294 L NO20073294 L NO 20073294L
Authority
NO
Norway
Prior art keywords
gpr39
protein
relates
compounds
coupled receptor
Prior art date
Application number
NO20073294A
Other languages
English (en)
Norwegian (no)
Inventor
Diederik Willem Elisa Moechars
Benoit Christian Jean- Moreaux
Theophiel Louis Henri Peeters
Inge Irma Therese Depoortere
Bernard Coulie
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20073294L publication Critical patent/NO20073294L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20073294A 2004-12-01 2007-06-28 G-proteinkoplet reseptor NO20073294L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04106220 2004-12-01
PCT/EP2005/056350 WO2006058889A1 (en) 2004-12-01 2005-11-30 G protein coupled receptor

Publications (1)

Publication Number Publication Date
NO20073294L true NO20073294L (no) 2007-08-29

Family

ID=34929976

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073294A NO20073294L (no) 2004-12-01 2007-06-28 G-proteinkoplet reseptor

Country Status (10)

Country Link
EP (1) EP1820026A1 (ja)
JP (1) JP2008521419A (ja)
KR (1) KR20070086003A (ja)
CN (1) CN101107529A (ja)
AU (1) AU2005311321A1 (ja)
CA (1) CA2587534A1 (ja)
NO (1) NO20073294L (ja)
RU (1) RU2007124609A (ja)
WO (1) WO2006058889A1 (ja)
ZA (1) ZA200704526B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7781175B2 (en) * 2004-04-23 2010-08-24 Takeda Pharmaceutical Company Limited Method of screening compounds which alter the binding properties of GPR39, and homologs thereof, to bile acid
MX2008015670A (es) * 2006-06-08 2009-01-12 Janssen Pharmaceutica Nv Receptor 39 acoplado a proteina g (gpr39).
CN111443209B (zh) * 2020-03-26 2022-12-20 中国中医科学院医学实验中心 一种筛选非激动剂型PPARγ配体的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1280937A2 (en) * 2000-04-26 2003-02-05 Millennium Pharmaceuticals, Inc. Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941
WO2002086460A1 (en) * 2001-04-20 2002-10-31 Consensus Pharmaceuticals, Inc. Methods for identifying ligands of g-protein-coupled receptors
US20030232769A1 (en) * 2002-06-17 2003-12-18 Isis Pharmaceuticals Inc. Antisense modulation of G protein-coupled receptor 39 expression
AU2003300776A1 (en) * 2002-09-09 2004-05-25 Omeros Corporation G protein coupled receptors and uses thereof
US20040071708A1 (en) * 2002-09-26 2004-04-15 Immusol, Inc. GPR 39 modulators that control cancerous cell growth
EP1558760B1 (en) * 2002-10-31 2010-12-22 Janssen Pharmaceutica N.V. Crh responsive genes in cns
US20080038247A1 (en) * 2003-05-05 2008-02-14 Bayer Healthcare Ag Diagnostics and Therapeutics for Diseases Associated With G-Protein-Coupled Receptor Gpr39 (Gpr39)

Also Published As

Publication number Publication date
CA2587534A1 (en) 2006-06-08
AU2005311321A1 (en) 2006-06-08
ZA200704526B (en) 2008-11-26
CN101107529A (zh) 2008-01-16
KR20070086003A (ko) 2007-08-27
JP2008521419A (ja) 2008-06-26
WO2006058889A1 (en) 2006-06-08
EP1820026A1 (en) 2007-08-22
RU2007124609A (ru) 2009-01-10

Similar Documents

Publication Publication Date Title
Mompeón et al. Estradiol, acting through ERα, induces endothelial non-classic renin-angiotensin system increasing angiotensin 1–7 production
Weyermann et al. A practical note on the use of cytotoxicity assays
MA31760B1 (fr) Compositions et procédés pour l'utilisation d'anticorps contre la sclérostine
NO20083011L (no) Modulatorer av muskarine receptorer
ATE516300T1 (de) Neuromedin-u-rezeptoragonisten und ihre verwendung
EA201100133A1 (ru) Антагонисты рецепторов простагландина d
MX2009004141A (es) Composiciones y metodos para modular receptores de c-kit y pdgfr.
EA200901646A1 (ru) Ингибиторы рецепторных тирозинкиназ и их применение
MA32982B1 (fr) Proteines de liaison au recepteur cgrp humain
ATE526585T1 (de) Natürlicher ligand des g-protein-gekoppelten rezeptors rcc356 und verwendungen davon
WO2007045927A3 (en) Therapeutic agent
MY159815A (en) Notch1 receptor binding agents and methods of use thereof
WO2007106721A3 (en) Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
EA201291181A1 (ru) Композиции и способы применения терапевтических поливалентных антител против белка, родственного рецептору липопротеинов низкой плотности 6 (lrp6)
Kuduk et al. Synthesis, Structure− Activity Relationship, and Pharmacological Profile of Analogs of The ASIC-3 Inhibitor A-317567
NO20091989L (no) Forbindelser som modulerer c-fms og/eller C-kit aktivitet og deres anvendelse
DE602006015686D1 (de) Als agonisten des gpr38-rezeptors geeignete biarylverbindungen
Davis et al. Role of mGluR4 in acquisition of fear learning and memory
WO2009059150A3 (en) Biomarkers for fatty liver disease and methods using the same
DE602005016800D1 (de) Hif-prolylhydroxylase-aktivitätstest
NO20074002L (no) Androgen reseptor-modulatorforbindelser og fremgangsmater
NO20074143L (no) Phuman T2R reseptorer for Acetaminophen, Ranitidine, Strychnine og Denatonium og relaterte analyser for identifisering av human bitter smak modulatorer
TW200636242A (en) Methods of modulating the activities of α7 nicotinic acetylcholine receptor
NO20082345L (no) Selektive VPAC2 reseptorpeptidagonister
WO2008008224A3 (en) Sour taste receptor compositions and methods

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application